Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 4 minutes ago
Back to Filings
FORM 8-K
AI

Current Report - September 6, 2022

Filed September 6, 2022
·
Period ending September 2, 2022
·
0000950170-22-018121

Appoints Dr. Edward H. Frank as independent Class II board director.

Brief

Rocket Lab expanded its Board from eight to nine directors and appointed Dr. Edward H. Frank as a Class II director effective September 2, 2022, with term expiring at the 2023 annual meeting. Dr. Frank, qualified as independent under Nasdaq standards, brings extensive tech leadership from Apple, Broadcom, and startups. Compensation includes prorated cash retainer and $360,000 initial RSU grant vesting over three years per standard policy.

Detailed Brief

On September 2, 2022, Rocket Lab USA, Inc. increased its Board size from eight to nine per its Amended and Restated Bylaws and appointed Dr. Edward H. Frank to the new Class II vacancy. Dr. Frank's initial term ends at the 2023 annual stockholder meeting. He is deemed independent for Nasdaq purposes. Background includes CEO of Brilliant Lime since 2017, VP at Apple (2009-2013), Corporate VP R&D at Broadcom, founder/CEO of Epigram (acquired by Broadcom). Current boards: Marvell, Analog Devices, SiTime. Compensation follows the Non-Employee Director Policy: prorated 2022 cash retainer, $360k initial RSUs vesting 1/3 annually over 3 years, future $180k annual RSUs vesting in one year or at next AGM (pro-rated first year). Full vesting acceleration on company sale. Standard indemnification agreement. No material related transactions or arrangements.

Key Telemetry

  • Board expanded 8 to 9 members; Dr. Edward H. Frank appointed Class II director on 2022-09-02.
  • Independent per Nasdaq; term to 2023 AGM.
  • Tech expertise: Apple Macintosh hardware VP, Broadcom R&D VP, Epigram founder.
  • Comp: $360k initial RSUs (3-yr vest), $180k annual RSUs (1-yr vest), prorated cash.
  • No related party transactions >$120k.

Impact Vector

Near-term: Bolsters board governance with proven tech/hardware executive, aiding Neutron development and scaling. No quantifiable financial impact; equity grants dilute minimally (~0.1% est.). Strategic: Enhances expertise in silicon/systems relevant to spacecraft/launch tech. Investors: Positive signal for leadership depth; hold/buy on governance strength.

Search
Search across missions, customers, news, and SEC filings